BURLINGTON, Mass.--(BUSINESS WIRE)-- #ADCs--Lifordi Immunotherapeutics, Inc., a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced a strategic investment from Sanofi Ventures, the venture arm of global healthcare leader Sanofi, and funding from existing investors ARCH Ventures, 5AM Ventures, and Atlas Venture. The new funds bring the total raised to $112 million and support an ongoing Phase 1 study in Rhe.

LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Avantor, Inc. ("Avantor" or the "Company") (NYSE: AVTR) have opportunity to lead the securities fraud class action lawsuit.

Ituran Location and Control Ltd. ( ITRN ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Eyal Sheratzky - Co-CEO & Director Eli Kamer - Executive VP & CFO Conference Call Participants Kenny Green Chris Reimer - Barclays Bank PLC, Research Division Allen Klee - Maxim Group LLC Sergey Glinyanov - Freedom Broker, Research Division Evan Tindell - Bireme Capital LLC Presentation Kenny Green Ladies and gentlemen, thank you for standing by.

Kanzhun Limited ( BZ ) Q3 2025 Earnings Call November 18, 2025 7:00 AM EST Company Participants Wenbei Wang - Head of Investor Relations & Capital Markets Peng Zhao - Founder, Chairman & CEO Yu Zhang - CFO & Executive Director Conference Call Participants Eddy Wang - Morgan Stanley, Research Division Wei Xiong - UBS Investment Bank, Research Division Timothy Zhao - Goldman Sachs Group, Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to Kanzhun Limited Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Today's conference is being recorded.

Marqeta, Inc. ( MQ ) Citi's 14th Annual FinTech Conference November 18, 2025 9:45 AM EST Company Participants Mike Milotich - CEO & CFO Conference Call Participants Bryan Keane - Citigroup Inc., Research Division Presentation Bryan Keane Citigroup Inc., Research Division All right. Let's do that again.

Henry Schein, Inc. ( HSIC ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Stanley Bergman - Executive Chairman & CEO Andrea Albertini - Chief Executive Officer of Global Distribution & Technology Graham Stanley - VP of Investor Relations & Strategic Finance Project Officer Conference Call Participants Michael Sarcone - Jefferies LLC, Research Division Presentation Michael Sarcone Jefferies LLC, Research Division Hi, everyone. My name is Mike Sarcone.

The bull case for generative AI may be losing steam. Analyst Alexander Haissl at Redburn is cutting his ratings on Microsoft and Amazon to neutral, saying the Gen-AI boom is NOT the next cloud.

Beazer Homes USA, Inc. faces near-term headwinds as home prices and new build activity decline, but remains fundamentally attractive for long-term investors. BZH's recent quarterly results exceeded analyst revenue and EPS expectations, despite falling profitability and a challenging housing market environment. The stock trades at low absolute valuation multiples but carries higher leverage than peers; BZH management is prioritizing deleveraging and community expansion.

AkzoNobel and Axalta Coating Systems have agreed to merge in an all-stock transaction that will combine the two companies into a global coatings business with an enterprise value of about $25 billion. The merger is structured as a merger of equals and is expected to create a company with approximately $17 billion in projected 2024 revenue.

CAMDEN, N.J.--(BUSINESS WIRE)-- #AmericanWater--American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., wants to help customers and the general public protect their residential plumbing and wastewater systems by providing important tips for disposal of Fats, Oils and Cooking Grease (FOGs). "Protecting your pipes isn't just about avoiding costly repairs—it's about safeguarding our communities and the local environment," said Mike Doran, Senior Vice President, Deputy Ch.

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO (plozasiran), a small interfering RNA (siRNA) medicine, as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). FCS is a severe, rare disease, with an estimated 6,500 people in the U.S. living with genetic or clinical FCS, characterized by triglyceride levels that can be 10 to 100 ti.

Investors Title Company (ITIC) is downgraded to 'hold' from 'buy' after strong share price gains and a lower-than-expected special dividend. ITIC reported higher Q3 revenue and net profit, driven by increased premiums and services, with controlled expenses boosting EPS over 20% year-over-year. The special dividend was set at $8.72 per share, below last year's $14, despite robust earnings and a positive housing market outlook.

AngloGold Ashanti (AU) delivered record Q3 2025 free cash flow of $920M, driven by strong gold prices, production growth, and cost control. AU achieved a 61% year-over-year increase in gold sales revenue and a 185% surge in net income, with EBITDA margin expanding from 51% to 66%. Operational highlights include robust African mine contributions, especially from Sukari, and disciplined cost management, supporting a 9% FCF yield and 4.5% dividend yield.

Boston Scientific Corporation ( BSX ) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 8:00 AM EST Company Participants Ken Stein - Senior VP & Global Chief Medical Officer Lauren Tengler - Director of Investor Relations Conference Call Participants Michael Polark - Wolfe Research, LLC Presentation Michael Polark Wolfe Research, LLC Good morning. Welcome, everybody.

Revolution Medicines, Inc. ( RVMD ) Jefferies London Healthcare Conference 2025 November 18, 2025 4:30 AM EST Company Participants Mark Goldsmith - CEO, President & Chairman Conference Call Participants Yuxi Dong - Jefferies LLC, Research Division Presentation Yuxi Dong Jefferies LLC, Research Division Good morning, everyone. Let's get started.

Eltek Ltd. ( ELTK ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Eli Yaffe - Chief Executive Officer Ron Freund - Chief Financial Officer Conference Call Participants Mark Sharogradsky Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Eltek Ltd.

Ford Motor Company ( F ) The Scotiabank Transportation & Industrials Conference November 18, 2025 9:00 AM EST Company Participants Andrew Frick - President of Ford Blue, Ford Model e & Lincoln Presentation Unknown Analyst I'm pleased to welcome our next company, Ford Motor Company. And from Ford, we have Andrew Frick, President of Ford Blue and Model e.

Energizer Holdings, Inc. ( ENR ) Q4 2025 Earnings Call November 18, 2025 10:00 AM EST Company Participants Jonathan Poldan - Vice President of Investor Relations & Treasurer Mark LaVigne - President, CEO & Director John Drabik - Executive VP & CFO Conference Call Participants Peter Grom - UBS Investment Bank, Research Division Lauren Lieberman - Barclays Bank PLC, Research Division Robert Ottenstein - Evercore ISI Institutional Equities, Research Division Shovana Chowdhury - JPMorgan Chase & Co, Research Division William Reuter - BofA Securities, Research Division Brian McNamara - Canaccord Genuity Corp., Research Division Presentation Operator Good morning. My name …